Zeria PharmceuticalZERIA PHARMCEUTICAL CO., LTD.4559東証プライム医薬品FY ending Mar 2026, consolidated, J-GAAP

What does Zeria Pharmceutical do with its cash?

How cash from operations was spent on investment, dividends, buybacks and more.

Operating cash flow
¥9.96B
Capex
¥2.9B
of revenue 3.2%
Free cash flow
¥7.06B
Returned to shareholders
¥2.11B
of net income: 25%
Dividend per share
¥49
Payout ratio (reported)
72.6%

Cash flow ratios

Cash conversion, investment and shareholder payments calculated from disclosed figures.

Net income¥8.45B
Operating cash flow¥9.96B
Cash conversion (operating CF ÷ operating income)
80.5%
Cash vs. profit gap
¥1.5B(純利益の 17.8%)
Shareholder returns
of net income 25.0% · of FCF 29.9%
Shareholder payments — dividends
of net income 24.9% · of FCF 29.9%
CapEx intensity (capex ÷ revenue)
3.2%
Investing CF relative to operating CF
27.1%

Nonpositive profit and free cash flow are omitted as ratio denominators. Amounts use the period's reported currency.

Five-year trend

Operating cash flow¥9.96B
FY ending Mar 2022: ¥8.95B¥8.95BFY ending Mar 2023: ¥13.2B¥13.2BFY ending Mar 2024: ¥12.2B¥12.2BFY ending Mar 2025: ¥12.9B¥12.9BFY ending Mar 2026: ¥9.96B¥9.96BFY22FY23FY24FY25FY26
Free cash flow¥7.06B
FY ending Mar 2022: ¥7.53B¥7.53BFY ending Mar 2023: ¥10.5B¥10.5BFY ending Mar 2024: ¥8.28B¥8.28BFY ending Mar 2025: ¥10.2B¥10.2BFY ending Mar 2026: ¥7.06B¥7.06BFY22FY23FY24FY25FY26
Net income¥8.45B
FY ending Mar 2022: ¥3.96B¥3.96BFY ending Mar 2023: ¥6.2B¥6.2BFY ending Mar 2024: ¥7.73B¥7.73BFY ending Mar 2025: ¥9.94B¥9.94BFY ending Mar 2026: ¥8.45B¥8.45BFY22FY23FY24FY25FY26

How to read this

  • Operating cash flow is the cash the core business actually brought in, including changes in receivables and inventory.
  • Free cash flow = operating cash flow − capital expenditure: a gauge of cash available for other uses.
  • Large "borrowing" or "cash drawdown" flows mean the company spent more than it generated that year.

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第72期(2025/04/01-2026/03/31)

    ID S100YKC22026-06-25Open
  • EDINET (FSA Japan)

    有価証券報告書-第71期(2024/04/01-2025/03/31)

    ID S100W62E2025-06-26Open
  • EDINET (FSA Japan)

    有価証券報告書-第70期(2023/04/01-2024/03/31)

    ID S100TWC62024-06-27Open
  • EDINET (FSA Japan)

    有価証券報告書-第69期(2022/04/01-2023/03/31)

    ID S100R8IH2023-06-29Open
  • EDINET (FSA Japan)

    有価証券報告書-第68期(令和3年4月1日-令和4年3月31日)

    ID S100OJZ32022-06-29Open
  • EDINET (FSA Japan)

    有価証券報告書-第67期(令和2年4月1日-令和3年3月31日)

    ID S100LRRP2021-06-29Open

Extracted from XBRL: 53 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.